ATE48417T1 - Pyridazin-derivate, wirksam auf das zentralnervensystem, verfahren zur herstellung, und diese enthaltende arzneimittel. - Google Patents

Pyridazin-derivate, wirksam auf das zentralnervensystem, verfahren zur herstellung, und diese enthaltende arzneimittel.

Info

Publication number
ATE48417T1
ATE48417T1 AT84400156T AT84400156T ATE48417T1 AT E48417 T1 ATE48417 T1 AT E48417T1 AT 84400156 T AT84400156 T AT 84400156T AT 84400156 T AT84400156 T AT 84400156T AT E48417 T1 ATE48417 T1 AT E48417T1
Authority
AT
Austria
Prior art keywords
manufacture
active
nervous system
central nervous
pyridazine derivatives
Prior art date
Application number
AT84400156T
Other languages
English (en)
Inventor
Jean-Pierre Chambon
Kathleen Biziere
Camille-Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE48417T1 publication Critical patent/ATE48417T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT84400156T 1983-01-27 1984-01-25 Pyridazin-derivate, wirksam auf das zentralnervensystem, verfahren zur herstellung, und diese enthaltende arzneimittel. ATE48417T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8301234A FR2540113A1 (fr) 1983-01-27 1983-01-27 Acides derives de la pyridazine actifs sur le systeme nerveux central
EP84400156A EP0117779B1 (de) 1983-01-27 1984-01-25 Pyridazin-Derivate, wirksam auf das Zentralnervensystem, Verfahren zur Herstellung, und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ATE48417T1 true ATE48417T1 (de) 1989-12-15

Family

ID=9285330

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84400156T ATE48417T1 (de) 1983-01-27 1984-01-25 Pyridazin-derivate, wirksam auf das zentralnervensystem, verfahren zur herstellung, und diese enthaltende arzneimittel.

Country Status (27)

Country Link
US (1) US4721711A (de)
EP (1) EP0117779B1 (de)
JP (1) JPS59141564A (de)
KR (1) KR910000638B1 (de)
AR (1) AR240045A1 (de)
AT (1) ATE48417T1 (de)
AU (2) AU2372984A (de)
CA (1) CA1238637A (de)
DD (1) DD220026A5 (de)
DE (1) DE3480653D1 (de)
DK (1) DK162985C (de)
ES (1) ES8500243A1 (de)
FI (1) FI78691C (de)
FR (1) FR2540113A1 (de)
HU (1) HU193890B (de)
IE (1) IE57054B1 (de)
IL (1) IL70756A (de)
MA (1) MA20018A1 (de)
NO (1) NO840313L (de)
NZ (1) NZ206945A (de)
OA (1) OA07644A (de)
PH (1) PH21162A (de)
PL (1) PL142340B1 (de)
PT (1) PT77993B (de)
SG (1) SG93690G (de)
YU (1) YU14284A (de)
ZA (1) ZA84502B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
EP0190563B1 (de) * 1985-01-14 1989-08-02 Boehringer Ingelheim Kg Neue 12-Amino-pyridazino[4',5':3,4]pyrrolo-[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
US5082939A (en) * 1987-01-08 1992-01-21 I.S.F. Societa Per Azioni Pyridazine derivatives
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
US5656631A (en) * 1989-02-07 1997-08-12 Sanofi Pyridazine derivatives
FR2668151A1 (fr) * 1990-10-23 1992-04-24 Rhone Poulenc Agrochimie Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant.
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
EP1430033A4 (de) * 2001-08-31 2004-12-15 Univ Northwestern Entzündunshemmende und proteinkinaseinhibierende zusammensetzung und deren verwendung
AU2005302225B2 (en) * 2004-11-02 2012-05-24 Centre National De La Recherche Scientifique Pyridazine compounds, compositions and methods
EP1812007B1 (de) * 2004-11-02 2011-09-07 Northwestern University Pyridazinverbindungen und verfahren
EP2015750A2 (de) * 2006-04-28 2009-01-21 Northwestern University Zusammensetzungen und behandlungen mit pyridazinverbindungen und cholisterinasehemmern
EP2015751A2 (de) * 2006-04-28 2009-01-21 Northwestern University Salze aus pyridazinverbindungen
EP2063894B1 (de) * 2006-04-28 2019-08-28 Northwestern University Formulierungen mit pyridazinverbindungen zur behandlung neuroinflammatorischer erkrankungen
BRPI0809498A2 (pt) * 2007-04-02 2014-09-23 Inst Oneworld Health Compostos inibidores de cftr e seus usos
US8236838B2 (en) * 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
US20090264433A1 (en) * 2008-04-21 2009-10-22 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Triazine Derivatives
WO2009131947A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising pyridazine derivatives
WO2009131957A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
EP2341776A4 (de) * 2008-09-19 2012-05-30 Inst Oneworld Health Verbindungen, zusammensetzungen und verfahren umfassend imidazol- und triazolderivate
US20100267706A1 (en) * 2009-04-20 2010-10-21 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
CA1218655A (en) * 1983-01-28 1987-03-03 Kathleen Biziere Process for the preparation of pyridazine derivatives having a psychotropic action

Also Published As

Publication number Publication date
DK162985C (da) 1992-06-01
FI78691B (fi) 1989-05-31
ZA84502B (en) 1984-09-26
DD220026A5 (de) 1985-03-20
FI840323A0 (fi) 1984-01-26
EP0117779B1 (de) 1989-12-06
IL70756A (en) 1987-03-31
YU14284A (en) 1986-12-31
ES529081A0 (es) 1984-10-01
AU652118B2 (en) 1994-08-18
SG93690G (en) 1991-01-18
IL70756A0 (en) 1984-04-30
PT77993A (fr) 1984-02-01
FI840323A (fi) 1984-07-28
DK38984D0 (da) 1984-01-27
AU2142188A (en) 1989-03-16
AR240045A1 (es) 1990-01-31
IE840149L (en) 1984-07-27
NZ206945A (en) 1987-07-31
DK38984A (da) 1984-07-28
PH21162A (en) 1987-08-05
JPS59141564A (ja) 1984-08-14
KR910000638B1 (ko) 1991-01-31
KR840007586A (ko) 1984-12-08
EP0117779A1 (de) 1984-09-05
CA1238637A (en) 1988-06-28
FR2540113B1 (de) 1985-05-17
DE3480653D1 (de) 1990-01-11
HU193890B (en) 1987-12-28
PL142340B1 (en) 1987-10-31
PL245931A1 (en) 1985-07-16
PT77993B (fr) 1986-04-10
FI78691C (fi) 1989-09-11
ES8500243A1 (es) 1984-10-01
NO840313L (no) 1984-07-30
IE57054B1 (en) 1992-04-08
DK162985B (da) 1992-01-06
OA07644A (fr) 1985-05-23
AU2372984A (en) 1984-08-02
US4721711A (en) 1988-01-26
FR2540113A1 (fr) 1984-08-03
MA20018A1 (fr) 1984-10-01

Similar Documents

Publication Publication Date Title
ATE48417T1 (de) Pyridazin-derivate, wirksam auf das zentralnervensystem, verfahren zur herstellung, und diese enthaltende arzneimittel.
DE3781195D1 (de) Substituierte benzamidderivate, verfahren zu deren herstellung und diese enthaltende medikamente.
NO871774D0 (no) Medikament-system med kontrollert frisettelse av det aktive middel.
DE3674752D1 (de) Alpha, alpha-trehalose-derivat und verfahren zur herstellung davon.
DE3680641D1 (de) Enzym-immobilisierte membran und verfahren zu deren herstellung.
DE3576500D1 (de) Carbostyrilverbindungen, diese enthaltende zubereitungen und verfahren zu ihrer herstellung.
ZA825513B (en) New derivatives of pyridazine active on the central nervous system
DE3779964D1 (de) Resistives bandelement, verfahren zur herstellung und verwendungen.
DE3675197D1 (de) Pyridinylpyrimidin-derivate, verfahren zu deren herstellung und diese als wirksamen stoff enthaltende pflanzenkrankheiten-schutzmittel.
AU579570B2 (en) New derivatives of pyridazine active on the central nervous system
DE3674818D1 (de) Katalysatorsystem und verfahren zur herstellung von alpha,omega-c4- bis c20-alkenolen.
DE3577199D1 (de) Semicarbazidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3667286D1 (de) Benzoxazinorifamycinderivat, verfahren zu seiner herstellung und diese enthaltende baktericide mittel.
DE3888443D1 (de) Verfahren zur Herstellung von Dihydrochinacridonen, Chinacridonen und Chinacridonchinonen.
ATE15369T1 (de) Verfahren zur herstellung von (thienyl-2)-2|thylaminen und(thienyl-3)-2-aethylaminen.
DE3670638D1 (de) Indol-3-yl-chinazolin-1,4-benzodiazepin-5,13-dione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3481418D1 (de) Substituierte spiropyridinderivate, diese enthaltende pharmazeutische zubereitungen, verfahren zu ihrer herstellung und zubereitungen.
DE3670289D1 (de) Verfahren zur herstellung von aryl-glycidyl-aethern und von 3-substituierten 1-alkylamino-2-propanolen.
DE3686148D1 (de) Lymphotoxin-gen, verfahren zu dessen herstellung und lymphotoxin.
DE3676360D1 (de) Nitroderivate von vinblastintyp-bis-indolen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE36329T1 (de) 5,6-dihydro-4h-cyclopenta(b)thiophen-6carbons|ure, verfahren zur herstellung und sie enthaltende arzneimittel.
ATE7392T1 (de) Vincamin-derivat, verfahren zur herstellung und das es enthaltende arzneimittel.
DE3679780D1 (de) Substituierte aminosulfonyl-6-nitrobenzosaeureester oder -amide, verfahren zur herstellung und diese enthaltende heilmittel.
DE3872916D1 (de) Herstellung und reinigung eines n,n-diethylaminophenols.
DE3667251D1 (de) Kristalliner borosilikatzeolith-katalysator, verfahren zur herstellung und verwendung desselben.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee